The share of US publications in the top 10% cited in transplantation is forecasted to slightly decrease from 13.55% in 2024 and 2025 to 13.54% in the period from 2026 to 2028. As of 2023, this share was at approximately 13.56%, indicating a minor decline over the following years. This suggests a stabilization of the US contribution to highly cited papers in this domain, with a minimal year-on-year decrease over the forecast period. The compounded annual growth rate (CAGR) indicates a steady state with no significant fluctuations anticipated.
Future trends to watch for include any shifts in research funding, collaborative efforts with international institutions, and advancements in transplantation technologies, which could impact the US's share in high-impact scientific literature. Monitoring these factors will be vital to understanding any potential changes in this percent share.
